Type 2 DiabetesNCT01333176
Point of Care HbA1c as a Screening Test for Type 2 Diabetes in First Nations
A study testing Point-of-care "finger-poke" HbA1c determination., HbA1c blood test and HbA1c finger poke test in people with Type 2 Diabetes, run by University of British Columbia at 1 site in Canada.
Trial summary
1. Purpose to estimate the prevalence of undiagnosed diabetes mellitus and pre-diabetes in a BC First Nation community to determine the utility of community based screening by examining how many positively screened people follow up with the recommended subsequent testing and family physician visit to determine if… Read more about this study
- Who is it for?
- Ages 14 years and olderHealthy volunteers can take part
- Conditions the study is for
- Type 2 Diabetes
- What is being tested?
- Point-of-care "finger-poke" HbA1c determination., HbA1c blood test and HbA1c finger poke test
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 320 participants
- Where
- 1 siteCanada
- Study dates
- Apr 2011to Dec 2012
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 14 years and older
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Members of Seabird Island or surrounding communities
- self-identified as First Nation1
- 14 years old and older
Who cannot join
- Known diabetes
- age less than fourteen years old
- pregnancy or less than six weeks post-partum
- medications known to interfere with glucose metabolism
- acute illness,
- life-expectancy of less than six months
Trial locations and contacts
1 site in 1 country.
Canada1 site, 1 recruiting
- Recruiting
Vancouver General Hospital
Vancouver, British Columbia, V5Z 1M9
Keith G Dawson, MD, 604-351-5565, kdaw@interchange.ubc.ca
Jessica MacKenzie-Feder, MD, 778-847-1466, jessmackfeder@yahoo.com
About this study
Official title: Community-based Screening for Diabetes Using a Validated Point-of-care HbA1c Assay in a British Columbia First Nations Community
- Purpose
- to estimate the prevalence of undiagnosed diabetes mellitus and pre-diabetes in a BC First Nation community
- to determine the utility of community based screening by examining how many positively screened people follow up with the recommended subsequent testing and family physician visit
- to determine if point-of-care HbA1c test (Ames/Bayer DCA 2000) correlates with the confirmatory fasting and 2 hour post challenge blood glucose tests.
- Hypothesis The Point-of-Care test will correlate well with the gold standard diagnostic tests and prove to be a useful tool for community-based screening. This test obviates the need for fasting and repeat glucose tolerance testing.
Read the detailed description
This is a screening for prevalence study.
The Seabird Island Band's health department serves a large catchment area of approximately 3000 First Nation members. The team of physicians, nurses, and technicians will invite communities to participate in diabetes screening events. In conjunction with the community health workers, we will be facilitating diabetes awareness in the community through the provision of large scale screening Two types of events will be held. An initial "Open House" event and a second event in the form of an afternoon "Diabetes Awareness" event later in the year.
With the assistance of community leaders and the Seabird Island Health Unit staff, we will utilize materials such as posters and flyers available from the Health unit both to increase awareness of diabetes and to advise of the awareness/screening events. For the Community Event there will be a community dinner served at the end of the afternoon for all who attended.
Community members of Seabird Island will be invited for screening through posters hung in gathering spaces and high traffic areas. Notices will be put in the community newsletter.
They will be given information about the screening study and will give informed consent by way of a formal consent form. If younger than 18, consent will be obtained from parents or guardians. Identity will be concealed by using study numbers for individuals; a master list linking names and PHNs to the study numbers will be kept by the Seabird Island lead for the study at Seabird Island in a locked cabinet in a locked office. Primary and Co-investigators will receive only anonymized data. This is the wish of the community and is in keeping with OCAP principles.
Tests and Procedure:
Point of care (finger poke) HbA1c using Ames/Bayer DCA 2000 POC analyzer system will be used for screening.
- If the A1c test result is < 6%: Will be offered to have a fasting and 2 hour after glucose drink test (OGTT) the next day. Otherwise will be counseled to follow up in one year with their Primary Care Physician or attend another screening opportunity
- If A1c result is 6-6.5: Given lab requisition for fasting blood sugar and HbA1c and 2 hour after glucose drink test (OGTT). Advised to get follow up blood work tomorrow (in some cases this will be available in the community) and advised to see their family physician. If the family physician is not a Seabird physician, a letter will be sent to the physician informing him of the screening event and the screening results. Counseled about health promotion and diabetes and meaning of A1c result.
- If A1c result is >6.5: Counseled that they may have diabetes. Given requisition to obtain a fasting and two hour post glucose drink test (OGTT) tomorrow and advised to see their family physician. Counseled about health promotion and diabetes and meaning of A1c result.
If history of gestational diabetes and not retested - given requisition for 75 g OGTT and counseled to follow up with family physician. If the family physician is not a Seabird physician, a letter will be sent to the physician informing him of the screening event and the screening results. Counseled about health promotion and diabetes and meaning of A1c result.
If blood pressure > 140/90 - counseled to follow up with family physician. If the family physician is not a Seabird physician, a letter will be sent to the physician informing him of the screening event and the screening results.
The Seabird lead will be notified of the blood results and record them along with the screening results. Anonymized data will be forwarded to the investigative team. We recognize that a small proportion of the sample (approximately 15%) that have non-Seabird physicians may not have follow-up data available.
All participants will have received information regarding diet, lifestyle, and diabetes prevention. They will also be given general counseling regarding the role of balance in health, and the fact that the traditional medicine wheel identifies Physical, Spiritual, Mental and Emotional aspects of health that affect blood glucose levels.
Estimates will be made (based on this sample of the population) about how many people have undiagnosed diabetes in this community, that is the number not known to have self-reported diabetes but who have an A1c test >6.5%. Specifically, if the A1c test is greater than 6.5% this is considered diagnostic of diabetes (by current American Diabetes Association standards) This will be compared to the number who have diabetes based on a fasting glucose > 7 mmol/L and/or 2 hour post glucose drink blood glucose test > 11 mmol/L on follow up testing (by current Canadian Diabetes Association guidelines) As well, comparison of the reverse will be made, namely those with elevated fasting and/or post glucose drink values but who had normal A1c values (<6.5%)
Additional outcomes:
- Did the clients who were counseled to do so actually obtain the follow-up blood tests? (Historically, such patients often decline to obtain the tests requested).
- Were all the follow-up blood tests performed? How many declined one or more of these tests, specifically the 2 hour post glucose drink test which is often refused).
- Did the formal tests correlate to the POC HbA1c test or was there significant discrepancy? Thus is this test for diagnosing diabetes confirmed as a valid test for screening in First Nation Communities in Canada?
- By one month post screening survey, how what percentage of family physicians found this useful?
Follow up information will be obtained and analyzed:
- Dr. Fox (main Seabird physician) will be contacted 1 month after the screening day to follow up on patient visits and on outpatient blood work for which clients were given requisitions. He will be asked if he noticed any benefits of this program.
- After 3 months, Dr. Fox will be re-contacted to check for outstanding results.
- At 4 months, if follow-up blood work has not been performed, clients will be contacted individually by telephone by Seabird Health to be reminded and to find out why they did not follow through with the blood tests.
- Statistical Analysis
Primary end point: How many clients (all of whom claimed not to have known diabetes) had HbA1c > 6.5%? This number indicates the prevalence of unknown diabetes in this First Nation community. And how many clients had a fasting glucose >7% and 2 hour post glucose drink glucose level >11%? Comparison of these two groups of results will indicate the correlation of the A1c test with the conventional glucose diagnostic tests in this First Nation population.
Secondary end points:
How many clients had an HbA1c > 6% but <6.5% and therefore have pre-diabetes. How many clients have hypertension with Blood pressure > 140/90. How many clients with a history of gestational diabetes and no follow up OGTT had diabetes (HbA1c >6.5%)
Sample size: If n=320 and we observe a prevalence of diabetes of 10%, then the absolute margin of error (the 95% confidence interval for the observed proportion) is +/- 3.3%, 19 times out of 20.
- Conditions
- Type 2 Diabetes
- Being tested
- Point-of-care "finger-poke" HbA1c determination., HbA1c blood test, HbA1c finger poke test, Blood test
- Keywords
- Type 2 Diabetes, Hb A1c screening for diabetes in aboriginals
- Medical subject headings
- Diabetes Mellitus, Type 2
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Point-of-care "finger-poke" HbA1c determination.Procedure or surgery
Also called Ames/Bayer DCA 2000 Hemoglobin A1c Assay
All volunteers receive finger-poke HbA1c test. Result: If < 6: Offered a requisition to have gold standard testing for diabetes screening. If 6-6.5: Given requisition for FBG, HbA1c and OGTT. If A1c result >6.5: Counseled that they may have diabetes. Given requisition as above.
Estimates about how many have undiagnosed diabetes will be calculated.
- Did the clients who were counseled to do so get follow-up blood tests?
- Were all the formal diagnostic tests performed?
- Did the formal tests correlate to the POC HbA1c test or was there significant discrepancy? Thus is this new test for diagnosing diabetes confirmed as a valid test for screening in First Nation Communities in Canada?
- Did the family physicians find this useful?
HbA1c blood testProcedure or surgery
All candidates will have a HbA1c blood test (Finger poke)
HbA1c finger poke testProcedure or surgery
All study candidates will have the same HbA1c test performed
Blood testProcedure or surgery
HbA1c blood test
Blood testProcedure or surgery
HbA1c finger poke blood test
| Study group | Role | What they receive |
|---|---|---|
| All volunteers have HbA1c test | Experimental | All candidates receive same procedure Receives: Procedure: Point-of-care "finger-poke" HbA1c determination.; Procedure: HbA1c blood test; Procedure: HbA1c finger poke test; Procedure: Blood test |
What is being measured
The primary outcome is the main question the study is designed to answer.
Does the HbA1c identify the same individuals as fasting and 2-hr pc glucose tests to identify diabetes and pre-diabetes in a First Nation community
We will obtain A1c, fasting glucose, and 2 hour post glucose drink glucose tests in First Nation volunteers. An A1c result of 6-6.4% will be considered diagnostic of pre-diabetes, a result ≥6.5% diabetes, a fasting glucose of 6.1-6.9 mmol/L pre-diabetes, and a fasting glucose ≥7 mmol/L, diabetes. Individual A1c results will be compared to fasting and 2 hour post glucose drink results. We will determine the sensitivity and specificity of the A1c test compared to the fasting and post glucose drink glucose tests.
Measured: One Month between individual comparative samples; One year for recruitment of all subjects.
Secondary outcomes (2)
Provide estimates of prevalence of diabetes and prediabetes in a First Nation community
To estimate the prevalence of undiagnosed diabetes mellitus and pre-diabetes in a random sample of the population from Seabird Island First Nation community.
Measured: One year
To identify the response rate of "gold standard" diabetes testing in a First nation community
To determine what percentage of those screened "positive" or "at risk" follow up with recommendations for formalized testing and follow up with family physician.
Measured: One Year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Apr 2011 (estimated)
- Study startApr 2011
- Primary completionJun 2012 (estimated)
- Study completionDec 2012 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Type 2 DiabetesStudies of the same condition, open and under way.
- More trials run by University of British ColumbiaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 320 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of British Columbia
- Sponsor type
- University, hospital or other
- Collaborators
- Vancouver General Hospital
- Responsible party
- Sponsor
- Investigators
- Jessica MacKenzie-Feder, MD, Study director, University of British ColumbiaSandra Sirrs, MD, Study director, Universithy of British Columbia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01333176
- Sponsor's protocol ID
- H10-02551
- Status last verified
- Apr 2012
- First submitted
- 5 Apr 2011
- Last updated
- 25 Apr 2012
- Results posted
- No
- Data monitoring committee
- No
Publications
Piette JD, Milton EC, Aiello AE, Mendoza-Avelares MO, Herman WH. Comparison of three methods for diabetes screening in a rural clinic in Honduras. Rev Panam Salud Publica. 2010 Jul;28(1):49-57. doi: 10.1590/s1020-49892010000700008.
PubMed 20857021
Study at a glance
From the registry record, last updated by the sponsor on 25 Apr 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Community-based Screening for Diabetes Using a Validated Point-of-care HbA1c Assay in a British Columbia First Nations Community
- ClinicalTrials.gov ID
- NCT01333176
- Acronym / sponsor ID
- H10-02551
- Conditions
- Type 2 Diabetes
- Keywords
- Type 2 Diabetes, Hb A1c screening for diabetes in aboriginals
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 320 participants (estimated)
- Lead sponsor
- University of British ColumbiaUniversity, hospital or other
- Collaborators
- Vancouver General Hospital
- Study start
- Apr 2011
- Primary completion
- Jun 2012 (estimated)
- Study completion
- Dec 2012 (estimated)
- First posted
- 11 Apr 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
- Purpose
- to estimate the prevalence of undiagnosed diabetes mellitus and pre-diabetes in a BC First Nation community
- to determine the utility of community based screening by examining how many positively screened people follow up with the recommended subsequent testing and family physician visit
- to determine if point-of-care HbA1c test (Ames/Bayer DCA 2000) correlates with the confirmatory fasting and 2 hour post challenge blood glucose tests.
- Hypothesis The Point-of-Care test will correlate well with the gold standard diagnostic tests and prove to be a useful tool for community-based screening. This test obviates the need for fasting and repeat glucose tolerance testing.
Detailed description
This is a screening for prevalence study.
The Seabird Island Band's health department serves a large catchment area of approximately 3000 First Nation members. The team of physicians, nurses, and technicians will invite communities to participate in diabetes screening events. In conjunction with the community health workers, we will be facilitating diabetes awareness in the community through the provision of large scale screening Two types of events will be held. An initial "Open House" event and a second event in the form of an afternoon "Diabetes Awareness" event later in the year.
With the assistance of community leaders and the Seabird Island Health Unit staff, we will utilize materials such as posters and flyers available from the Health unit both to increase awareness of diabetes and to advise of the awareness/screening events. For the Community Event there will be a community dinner served at the end of the afternoon for all who attended.
Community members of Seabird Island will be invited for screening through posters hung in gathering spaces and high traffic areas. Notices will be put in the community newsletter.
They will be given information about the screening study and will give informed consent by way of a formal consent form. If younger than 18, consent will be obtained from parents or guardians. Identity will be concealed by using study numbers for individuals; a master list linking names and PHNs to the study numbers will be kept by the Seabird Island lead for the study at Seabird Island in a locked cabinet in a locked office. Primary and Co-investigators will receive only anonymized data. This is the wish of the community and is in keeping with OCAP principles.
Tests and Procedure:
Point of care (finger poke) HbA1c using Ames/Bayer DCA 2000 POC analyzer system will be used for screening.
- If the A1c test result is < 6%: Will be offered to have a fasting and 2 hour after glucose drink test (OGTT) the next day. Otherwise will be counseled to follow up in one year with their Primary Care Physician or attend another screening opportunity
- If A1c result is 6-6.5: Given lab requisition for fasting blood sugar and HbA1c and 2 hour after glucose drink test (OGTT). Advised to get follow up blood work tomorrow (in some cases this will be available in the community) and advised to see their family physician. If the family physician is not a Seabird physician, a letter will be sent to the physician informing him of the screening event and the screening results. Counseled about health promotion and diabetes and meaning of A1c result.
- If A1c result is >6.5: Counseled that they may have diabetes. Given requisition to obtain a fasting and two hour post glucose drink test (OGTT) tomorrow and advised to see their family physician. Counseled about health promotion and diabetes and meaning of A1c result.
If history of gestational diabetes and not retested - given requisition for 75 g OGTT and counseled to follow up with family physician. If the family physician is not a Seabird physician, a letter will be sent to the physician informing him of the screening event and the screening results. Counseled about health promotion and diabetes and meaning of A1c result.
If blood pressure > 140/90 - counseled to follow up with family physician. If the family physician is not a Seabird physician, a letter will be sent to the physician informing him of the screening event and the screening results.
The Seabird lead will be notified of the blood results and record them along with the screening results. Anonymized data will be forwarded to the investigative team. We recognize that a small proportion of the sample (approximately 15%) that have non-Seabird physicians may not have follow-up data available.
All participants will have received information regarding diet, lifestyle, and diabetes prevention. They will also be given general counseling regarding the role of balance in health, and the fact that the traditional medicine wheel identifies Physical, Spiritual, Mental and Emotional aspects of health that affect blood glucose levels.
Estimates will be made (based on this sample of the population) about how many people have undiagnosed diabetes in this community, that is the number not known to have self-reported diabetes but who have an A1c test >6.5%. Specifically, if the A1c test is greater than 6.5% this is considered diagnostic of diabetes (by current American Diabetes Association standards) This will be compared to the number who have diabetes based on a fasting glucose > 7 mmol/L and/or 2 hour post glucose drink blood glucose test > 11 mmol/L on follow up testing (by current Canadian Diabetes Association guidelines) As well, comparison of the reverse will be made, namely those with elevated fasting and/or post glucose drink values but who had normal A1c values (<6.5%)
Additional outcomes:
- Did the clients who were counseled to do so actually obtain the follow-up blood tests? (Historically, such patients often decline to obtain the tests requested).
- Were all the follow-up blood tests performed? How many declined one or more of these tests, specifically the 2 hour post glucose drink test which is often refused).
- Did the formal tests correlate to the POC HbA1c test or was there significant discrepancy? Thus is this test for diagnosing diabetes confirmed as a valid test for screening in First Nation Communities in Canada?
- By one month post screening survey, how what percentage of family physicians found this useful?
Follow up information will be obtained and analyzed:
- Dr. Fox (main Seabird physician) will be contacted 1 month after the screening day to follow up on patient visits and on outpatient blood work for which clients were given requisitions. He will be asked if he noticed any benefits of this program.
- After 3 months, Dr. Fox will be re-contacted to check for outstanding results.
- At 4 months, if follow-up blood work has not been performed, clients will be contacted individually by telephone by Seabird Health to be reminded and to find out why they did not follow through with the blood tests.
- Statistical Analysis
Primary end point: How many clients (all of whom claimed not to have known diabetes) had HbA1c > 6.5%? This number indicates the prevalence of unknown diabetes in this First Nation community. And how many clients had a fasting glucose >7% and 2 hour post glucose drink glucose level >11%? Comparison of these two groups of results will indicate the correlation of the A1c test with the conventional glucose diagnostic tests in this First Nation population.
Secondary end points:
How many clients had an HbA1c > 6% but <6.5% and therefore have pre-diabetes. How many clients have hypertension with Blood pressure > 140/90. How many clients with a history of gestational diabetes and no follow up OGTT had diabetes (HbA1c >6.5%)
Sample size: If n=320 and we observe a prevalence of diabetes of 10%, then the absolute margin of error (the 95% confidence interval for the observed proportion) is +/- 3.3%, 19 times out of 20.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| All volunteers have HbA1c test | Experimental | Procedure: Point-of-care "finger-poke" HbA1c determination., Procedure: HbA1c blood test, Procedure: HbA1c finger poke test, Procedure: Blood testAll candidates receive same procedure |
Who may qualify
- Ages
- 14 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (3 listed)
- Members of Seabird Island or surrounding communities
- self-identified as First Nation1
- 14 years old and older
Key exclusion criteria (6 listed)
- Known diabetes
- age less than fourteen years old
- pregnancy or less than six weeks post-partum
- medications known to interfere with glucose metabolism
- acute illness,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Point-of-care "finger-poke" HbA1c determination.Also: Ames/Bayer DCA 2000 Hemoglobin A1c AssayAll volunteers receive finger-poke HbA1c test. Result: If < 6: Offered a requisition to have gold standard testing for diabetes screening. If 6-6.5: Given requisition for FBG, HbA1c and OGTT. If A1c result >6.5: Counseled that they may have diabetes. Given requisition as above. Estimates about how many have undiagnosed diabetes will be calculated. 1. Did the clients who were counseled to do so get follow-up blood tests? 2. Were all the formal diagnostic tests performed? 3. Did the formal tests correlate to the POC HbA1c test or was there significant discrepancy? Thus is this new test for diagnosing diabetes confirmed as a valid test for screening in First Nation Communities in Canada? 4. Did the family physicians find this useful? | Procedure or surgery | All volunteers have HbA1c test |
| HbA1c blood testAll candidates will have a HbA1c blood test (Finger poke) | Procedure or surgery | All volunteers have HbA1c test |
| HbA1c finger poke testAll study candidates will have the same HbA1c test performed | Procedure or surgery | All volunteers have HbA1c test |
| Blood testHbA1c blood test | Procedure or surgery | All volunteers have HbA1c test |
| Blood testHbA1c finger poke blood test | Procedure or surgery | All volunteers have HbA1c test |
Primary outcome
Does the HbA1c identify the same individuals as fasting and 2-hr pc glucose tests to identify diabetes and pre-diabetes in a First Nation community
Time frame: One Month between individual comparative samples; One year for recruitment of all subjects.
We will obtain A1c, fasting glucose, and 2 hour post glucose drink glucose tests in First Nation volunteers. An A1c result of 6-6.4% will be considered diagnostic of pre-diabetes, a result ≥6.5% diabetes, a fasting glucose of 6.1-6.9 mmol/L pre-diabetes, and a fasting glucose ≥7 mmol/L, diabetes. Individual A1c results will be compared to fasting and 2 hour post glucose drink results. We will determine the sensitivity and specificity of the A1c test compared to the fasting and post glucose drink glucose tests.
2 secondary outcomes
Provide estimates of prevalence of diabetes and prediabetes in a First Nation community
Time frame: One year
To identify the response rate of "gold standard" diabetes testing in a First nation community
Time frame: One Year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Apr 2012.
- Background: PubMed 20857021Piette JD, Milton EC, Aiello AE, Mendoza-Avelares MO, Herman WH. Comparison of three methods for diabetes screening in a rural clinic in Honduras. Rev Panam Salud Publica. 2010 Jul;28(1):49-57. doi: 10.1590/s1020-49892010000700008.
Related trials for Type 2 Diabetes
Not yet recruitingPhase 3
Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes
Type 2 Diabetes
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Not yet recruitingPhase 3
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
Obesity, Overweight
Not yet recruiting
Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
Type 2 Diabetes Mellitus (T2D), Obesity (BMI>30)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jessica MacKenzie-Feder, MD study director
University of British Columbia
Sandra Sirrs, MD study director
Universithy of British Columbia
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Point-of-care "finger-poke" HbA1c determination., HbA1c blood test and HbA1c finger poke test in people with Type 2 Diabetes, run by University of British Columbia at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 25 Apr 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Keith G Dawson, MD, PhD (604-351-5565, kdaw@interchange.ubc.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Does the HbA1c identify the same individuals as fasting and 2-hr pc glucose tests to identify diabetes and pre-diabetes in a First Nation community (time frame: One Month between individual comparative samples; One year for recruitment of all subjects.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01333176, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2012.